Bulova Technologies Group, Inc. Climbs The Mountain. By

New Post Public Reply Private Reply Replies (0) Message Board
times2times2
1,190
Bulova Technologies Group, Inc. Climbs The Mountain.
By Gene Daniel - June 1, 2017
https://oracledispatch.com/2017/06/01/bulova-...-mountain/

Bulova Technologies Group, Inc. (OTCMKTS:BTGI) is a microcap conglomerate posting triple-digit gains after releasing a new revenue report. Shares of Florida-based Bulova Technologies Group, Inc. (OTCMKTS: BTGI) skyrocketed by more than 217.86% on May 31 after the company reported better than expected earnings for its most recent quarter. That has investors wondering how much higher this diversified conglomerate could head.

Shares of BTGI are now trading at $0.00890, giving the company a total market capitalization of $4.15 million. Over the most recent 52-week period, shares have traded as low as $0.00 and as high as $0.05. On a YTD basis, shares are up 423.53%. And just over the past five days, shares are up 187.1%.

What has investors so optimistic now are the most recent financial numbers. In 2Q 2017, Bulova Technologies Group, Inc. (OTCMKTS:BTGI) posted revenue of $6.259 million. And the company’s management reiterated an annual revenue target of $28.0 million. To make that target, revenue would only have to increase by 10-15% each quarter.

Like any diversified conglomerate, BTGI has its hands in a large number of businesses, many of them not related to each other at all. For example, the company runs a freight handling and transport business, and is also engaged in the commercial sale of computer numerical control (CNC) machines. These two business segments – freight transportation and industrial machine tools – are the main focus of BTGI.

But if you dig a little deeper into the company, BTGI seems to be engaged in far more than that. On the company’s website, BTGI mentions that one of its subsidiaries – Bulova Technologies Europe – has nothing at all to do with transportation or industrial machines. Instead, this subsidiary is engaged in the carrying out of military contracts, including the “movement of military articles across NATO borders.” Oh, and just for good measure, this subsidiary imports small caliber ammunition for the U.S. commercial ammunition marketplace.

And it’s not just military contracts where Bulova has a new business focus – it also has a healthcare subsidiary that’s engaged in the sale of Osteo FX, a material used to make orthopedic casts.

This diversification, of course, makes it slightly more difficult to value Bulova Technologies Group. Stock analysts who are bullish on the company make comparisons between Bulova Technologies Group and other well-known U.S. conglomerates, such as 3M and GE. Thus, just as GE is involved in a wide range of businesses, so is Bulova.

From that perspective, as long as Bulova continues to report higher revenue every quarter, it really doesn’t matter where the revenue is coming from – there are a wide range of businesses, and since they are so diversified, there’s only one that really needs to be doing well to make the quarterly revenue target.

The company has made some strategic moves that could act as near-term catalysts. In August 2016, Bulova acquired Florida-based Global Frozen Trucking. That would seem to be a strategic move that actually makes sense, given that Bulova is already active in freight handling and transport. It’s possible to see how that acquisition might actually drive bottom line results for Bulova. But the deal itself is not a blockbuster – it will only involve the addition of six late model trucks and seven refrigerated trailers to Bulova’s current transportation fleet.

However, what’s most concerning if you’re a skeptical investor is how little news Bulova seems to have about its other core business, especially the commercial sale of high precision industrial machine tools. Instead of press releases about new client wins or new projects, the company sent out a press release in 2016 saying that it had appeared at a Chicago manufacturing trade show and that people stopped by its booth at that trade show. In other words… so what?

It’s easy to see that Bulova Technologies Group could become a momentum play for some investors. The stock has shown the ability to post some spectacular gains within very short periods of time. But caveat emptor – it’s not really clear whether this industrial conglomerate has a true vision of where it wants to head next. For more news on Bulova Technologies Group and other fast-moving penny stocks, please subscribe to OracleDispatch.com below.

Bulova Technologies Group Inc. (BTGI) Stock Research Links

BTGI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 33

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 37

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 29

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 40

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from APA Corporation's Q3 2024 Financial Update

Updated Category News Views 291

Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...

Continue Reading
Exploring the Growing Trends in the US Coffee Market to 2034

Updated Category News Views 394

Insights on the US Coffee Market Growth The US coffee market is currently gearing up for an exciting decade ahead, with projections indicating it could reach USD 150.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% from 2025. This surge is largely influenced by shifting consumer preferences towards premium and specialty coffee, along with an...

Continue Reading
Insights into Great Lakes Dredge & Dock's Upcoming Earnings

Updated Category News Views 125

Understanding the Upcoming Earnings Announcement Great Lakes Dredge & Dock (NASDAQ: GLDD) is gearing up for its quarterly earnings report, and investors are eager to glean insights from the announcement. The anticipation is palpable as analysts forecast an earnings per share (EPS) of $0.09, signalling potential growth for the company. Market Reactions and Guidance It's...

Continue Reading
Calmére Estate Winery Sold, Signaling Growth in Napa Valley

Updated Category News Views 306

Calmére Estate Winery Changes Hands in Major Sale Napa Valley has long been a beacon for wine enthusiasts and savvy investors alike. The recent transaction involving Calmére Estate Winery showcases the continued potential of this iconic region. The winery, known for its exquisite Chardonnay and Pinot Noir, has been a part of the Carneros American Viticultural Area (AVA)...

Continue Reading
Mr. Splash Car Wash Partners with NBA Stars for Growth

Updated Category News Views 204

Mr. Splash Car Wash Takes a Strategic Step Forward Mr. Splash Car Wash, a notable name in the express car wash industry, has recently entered into a strategic partnership with NBA stars Giannis and Thanasis Antetokounmpo, along with Michael Carter-Williams. This collaboration aims to elevate the brand's presence in the Midwest, showcasing Mr. Splash's commitment to...

Continue Reading